Nizar J Bahlis

45PUBLICATIONS
213CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNanomedicineMedical bacteriologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 19, 2026
Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|May 05, 2026
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE.

|Feb 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

C Riedhammer, M Truger, H Lee

|Jan 15, 2026
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.

Holly Lee, Sungwoo Ahn, Gerone A Gonzales

Pageof 8

Frequent Collaborators

9 joint publications

Saad Z Usmani

8 joint publications

Aurore Perrot

7 joint publications

Philippe Moreau

7 joint publications

María-Victoria Mateos